Abstract:Background: The tight coupling between osteoblasts and osteoclasts is essential to maintain bone homeostasis. Deregulation of this process leads to loss and deterioration of the bone tissue causing diseases, such as osteoporosis. MicroRNAs are able to control bone-related mechanisms and have been explored as therapeutic tools. In this study, we investigated the potential of miR-99a-5p to modulate osteogenic differentiation, osteoclastogenesis, and the osteoblasts-osteoclasts crosstalk. Methods: To achieve this goal, human primary Mesenchymal Stem/Stromal Cells (MSC) were differentiated into osteoblasts and adipocytes, and miR-99a-5p expression was evaluated by RT-qPCR. Knockdown and overexpression experiments were conducted to modulate miR-99a-5p expression in MC3T3 cells. Cell proliferation and cell death/apoptosis were evaluated by resazurin assay and flow cytometry, respectively. Proteomic analysis was used to identify the miR-99a-5p regulatory network, and ELISA to evaluate OPG levels in the cell culture supernatant. Conditioned media from MC3T3-transfected cells was used to culture RAW 264.7 cells and the effect on osteoclast differentiation was assessed. Human primary monocytes were isolated to induce osteoclastogenesis and evaluate miR-99a-5p expression. Finally, levels of miR-99a-5p were modulated in RAW 264.7 cells to understand the impact on osteoclastogenesis. Results: The results show that miR-99a-5p is significantly downregulated during the early stages of human primary MSCs osteogenic differentiation and during MC3T3 osteogenic differentiation. On the other hand, miR-99a-5p levels are increased during the initial stages of adipogenic differentiation. Inhibition of miR-99a-5p in MC3T3 pre-osteoblastic cells promoted osteogenic differentiation, whereas its overexpression suppressed the levels of osteogenic specific genes (Runx2 and Alpl), as well as mineralization, with no effect on proliferation or apoptosis. Proteomic analysis of miR-99a-5p-transfected cells showed that numerous proteins known to be involved in cell differentiation were altered, including osteogenic differentiation markers and extracellular matrix proteins. While inhibition of miR-99a-5p increased the Tnfrsf11b (OPG encoding gene)/Tnfsf11 (RANKL encoding gene) mRNA expression ratio, in addition to increasing OPG secretion, miR-99a-5p overexpression resulted in the opposite effect. The cell culture supernatant of miR-99a-5p-inhibited MC3T3 cells impaired the osteoclastogenic potential of RAW 264.7 cells by decreasing the number of multinucleated cells and reducing the expression of osteoclastogenic markers. Interestingly, miR-99a-5p expression is increased during osteoclasts differentiation, both in human primary monocytes and RAW 264.7. These results show that miR-99a-5p per se is a positive regulator of osteoclastogenic differentiation. Conclusions: Globally, our findings show that miR-99a-5p inhibition promotes the commitment into osteogenic differentiation, impairs osteoclastogenic differentiation, and control bone cells communication. Ultimately, it supports miR-99a-5p as a target candidate for future miRNA-based therapies for bone diseases associated with bone remodeling deregulation.

MiR-9 promotes osteoblast differentiation of mesenchymal stem cells by inhibiting DKK1 gene expression

MicroRNA-155 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells Induced by BMP9 Via Downregulation of BMP Signaling Pathway.

Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells by regulating DKK1 via targeting miR‐103a‐3p

Overexpression of Mir-155 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells C3H10T1/2 Induced by BMP9

miR-155 Suppresses the Osteogenic Differentiation of Mesenchymal Stem Cells Line C3H10T1/2 via Down-Regulation of BMP9/Smad Signal Pathway

Dickkopf-1 is involved in BMP9-induced osteoblast differentiation of C3H10T1/2 mesenchymal stem cells

miR‐483‐3p promotes the osteogenesis of human osteoblasts by�targeting Dikkopf 2 (DKK2) and the Wnt signaling pathway

Biological Role of miRNA-302a-3p/DKK1 in Osteogenesis of Bone-Marrow Derived Mesenchymal Stem Cells

Mir-214 Suppresses the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and These Effects Are Mediated Through the Inhibition of the JNK and P38 Pathways.

MicroRNA-99a is a novel regulator of KDM6B-mediated osteogenic differentiation of BMSCs

miR-1249-5p regulates the osteogenic differentiation of ADSCs by targeting PDX1

MicroRNA-409-3p promotes osteoblastic differentiation via activation of Wnt/β-catenin signaling pathway by targeting SCAI

KLF9 regulates osteogenic differentiation of mesenchymal stem cells

Mir-203a-5p Decreases The Expression Of Runx2 And Inhibits The Differentiation Of Bmscs To Osteoblasts

MiR-9-1 controls osteoblastic regulation of lymphopoiesis

[Effect of MiR-99a-5p on the Differential Ability of Human Bone Marrow Mesenchymal Stem Cells].

miR-342-5p inhibits expression of Bmp7 to regulate proliferation, differentiation and migration of osteoblasts

miR-99a in bone homeostasis: Regulating osteogenic lineage commitment and osteoclast differentiation

Mirna-140 Inhibits C3H10T1/2 Mesenchymal Stem Cell Proliferation by Targeting CXCL12 During Transforming Growth Factor-Β3-induced Chondrogenic Differentiation.

Mir-21 Synergizes with BMP9 in Osteogenic Differentiation by Activating the BMP9/Smad Signaling Pathway in Murine Multilineage Cells.

MiR-486–3p promotes osteogenic differentiation of BMSC by targeting CTNNBIP1 and activating the Wnt/β-catenin pathway